Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases

Autor: Peter Wich, Quian Peter Su, Vipan K. Parihar, Keshav Raj Paudel, Philip M. Hansbro, Vinod Kumar Kannaujiya, Kamal Dua, Meenu Mehta, Niraj Kumar Jha, Venkata Sita Rama Raju Allam, Amlan Chakraborty, Amlan Das, Nisha Panth, Shakti D. Shukla, Jon Adams, Dikaia Xenaki, Dinesh Kumar Chellappan, Khadem Ali, Brian G. Oliver

Publikováno v: Mehta, M, Paudel, K R, Shukla, S D, Allam, V S R R, Kannaujiya, V K, Panth, N, Das, A, Parihar, V K, Chakraborty, A, Ali, M K, Jha, N K, Xenaki, D, Su, Q P, Wich, P R, Adams, J, Hansbro, P M, Chellappan, D K, Oliver, B G G & Dua, K 2021, ' Recent trends of NFkB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases ', Journal of Controlled Release, vol. 337, pp. 629-644 . https://doi.org/10.1016/j.jconrel.2021.08.010

Nuclear factor κB (NFκB) is a unique protein complex that plays a major role in lung inflammation and respiratory dysfunction. The NFκB signaling pathway, therefore becomes an avenue for the development of potential pharmacological interventions,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::800b91932a21a54caf3abe5becfd0839
https://pubmed.ncbi.nlm.nih.gov/34375688